Delivery Order SPE2DB22D2009-SPE2DB24FL6CP

Award Date 10/24/23
Potential Completion Date 10/25/23
Potential Value $16K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $77,021.70 firm-fixed-price delivery order is for 4564450110 - BIKTARVY 50-200-25 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,159.67 firm fixed-price delivery order is for the supply of BIKTARVY 50-200-25 MG TABLET, a prescription medication. The contract has an ultimate completion date of September 21, 2023. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
The federal contract award, valued at $2,012.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET. The contract is a delivery order with a firm fixed price and has an ultimate completion date of April 25, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,966.92, is for the delivery of BIKTARVY 50-200-25 MG TABLET medical supplies. The contract has an ultimate completion date of February 19, 2025 and is a firm fixed-price delivery order. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $15,275.33, is for the delivery of Biktarvy 50-200-25 MG Tablet, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $29,351.69, is for the delivery of the pharmaceutical product BIKTARVY 50-200-25 MG TABLET in units of 30. The contract has a completion date of March 13, 2024 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $39,847.58 fixed-price delivery order is for the provision of BIKTARVY 50-200-25 MG TABLET medical products. The contract has an ultimate completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 MG TABLET to the Defense Logistics Agency (DLA). The award, valued at $97,947.83, is a Firm Fixed Price Delivery Order contract with a completion date of September 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also registered as a federal contractor. The contract does not have a set-aside designation,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $54,991.16 for the supply of BIKTARVY 50-200-25 MG TABLET. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of March 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,305.87, is for the delivery of BIKTARVY 50-200-25 MG TABLET in quantities of 30s. The contract is a firm-fixed-price delivery order with a completion date of January 15, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL6CP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BIKTARVY 50-200-25 MG TABLET medical supplies. The contract has a ceiling value of $15,567.95 and an ultimate completion date of October 25, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, running through December 2025. This IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. Cencora, Inc. also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/12/25, 10:31 AM